Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 46716 questions Show Answers
To ask the Scottish Government which NHS boards prescribe cladribine (Mavenclad) to treat multiple sclerosis (MS); how many patients in each NHS board are receiving this disease modifying therapy, and what its position is on whether it should be prescribed to appropriate patients.
To ask the Scottish Government which NHS boards prescribe ozanimod (Zeposia) to treat multiple sclerosis (MS); how many patients in each NHS board are receiving this disease modifying therapy, and what its position is on whether it should be prescribed to appropriate patients.
To ask the Scottish Government which NHS boards prescribe glatiramer acetate (Copaxone) to treat multiple sclerosis (MS); how many patients in each NHS board are receiving this disease modifying therapy, and what its position is on whether it should be prescribed to appropriate patients.
To ask the Scottish Government which NHS boards prescribe siponimod (Mayzent) to treat multiple sclerosis (MS); how many patients in each NHS board are receiving this disease modifying therapy, and what its position is on whether it should be prescribed to appropriate patients.
To ask the Scottish Government, further to the answer to question S6F-03284 by John Swinney on 5 September 2024, how it is working to lower waiting times for urology operations classified as urgent by NHS Scotland.
To ask the Scottish Government what multi-year funding it can provide to advice services on the Western Isles to ensure that islanders are able to continue to access free legal advice.
To ask the Scottish Government which NHS boards prescribe natalizumab (Tysabri) to treat multiple sclerosis (MS); how many patients in each NHS board are receiving this disease modifying therapy, and what its position is on whether it should be prescribed to appropriate patients.
To ask the Scottish Government whether it will provide an update on the implementation of the Scottish Offshore Wind Energy Council’s collaborative framework charter and its development of a strategic investment model.
To ask the Scottish Government what action it is taking to enhance the education and training of healthcare professionals on hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorder (HSD).
To ask the Scottish Government what action it is taking to establish a pathway of care for individuals with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorder (HSD).